Lilyana Amezcua1, Jessica B Smith1, Edlin G Gonzales1, Samantha Haraszti1, Annette Langer-Gould2. 1. From the Department of Neurology (L.A.), University of Southern California, Keck School of Medicine, Los Angeles; Department of Research & Evaluation (J.B.S., E.G.G.) and Los Angeles Medical Center, Department of Neurology (A.L.-G.), Southern California Permanente Medical Group, Pasadena; and Philadelphia College of Osteopathic Medicine (S.H.), PA. 2. From the Department of Neurology (L.A.), University of Southern California, Keck School of Medicine, Los Angeles; Department of Research & Evaluation (J.B.S., E.G.G.) and Los Angeles Medical Center, Department of Neurology (A.L.-G.), Southern California Permanente Medical Group, Pasadena; and Philadelphia College of Osteopathic Medicine (S.H.), PA. annette.m.langer-gould@kp.org.
Abstract
OBJECTIVE: To determine whether black or Hispanic patients with newly diagnosed multiple sclerosis (MS) are more likely to have cognitive impairment than white patients when compared to controls matched on age, sex, and race/ethnicity. Whether black or Hispanic patients have a more aggressive MS disease course than white patients remains unclear. No prior studies have examined differences in early cognitive impairment. The oral Symbol Digit Modalities Test (SDMT) is sensitive to early cognitive impairment in MS but normative data in nonwhite patients are limited. METHODS: We studied 1,174 adults who enrolled in the MS Sunshine Study. SDMT and verbal fluency were measured in 554 incident cases of MS or clinically isolated syndrome (CIS) and 620 matched controls. Multivariable regression was used to examine correlates of abnormal SDMT in the entire cohort. RESULTS: The strongest independent predictors of lower oral SDMT scores in rank order were having MS/CIS, lower educational attainment, and being black or Hispanic. Black and Hispanic patients and controls had lower SDMT scores than white participants even after controlling for age, sex, and education. However, no interaction between race/ethnicity and MS case status on SDMT scores was detected. Easy-to-use reference scores stratified by age and educational attainment for black and Hispanic patients are provided. CONCLUSION: Persons with newly diagnosed MS/CIS are more likely to have subtly impaired cognitive function than controls regardless of race/ethnicity. Lower absolute SDMT scores among black and Hispanic patients compared to white patients highlight underlying US population differences rather than differences in MS disease severity.
OBJECTIVE: To determine whether black or Hispanic patients with newly diagnosed multiple sclerosis (MS) are more likely to have cognitive impairment than white patients when compared to controls matched on age, sex, and race/ethnicity. Whether black or Hispanic patients have a more aggressive MS disease course than white patients remains unclear. No prior studies have examined differences in early cognitive impairment. The oral Symbol Digit Modalities Test (SDMT) is sensitive to early cognitive impairment in MS but normative data in nonwhite patients are limited. METHODS: We studied 1,174 adults who enrolled in the MS Sunshine Study. SDMT and verbal fluency were measured in 554 incident cases of MS or clinically isolated syndrome (CIS) and 620 matched controls. Multivariable regression was used to examine correlates of abnormal SDMT in the entire cohort. RESULTS: The strongest independent predictors of lower oral SDMT scores in rank order were having MS/CIS, lower educational attainment, and being black or Hispanic. Black and Hispanic patients and controls had lower SDMT scores than white participants even after controlling for age, sex, and education. However, no interaction between race/ethnicity and MS case status on SDMT scores was detected. Easy-to-use reference scores stratified by age and educational attainment for black and Hispanic patients are provided. CONCLUSION: Persons with newly diagnosed MS/CIS are more likely to have subtly impaired cognitive function than controls regardless of race/ethnicity. Lower absolute SDMT scores among black and Hispanic patients compared to white patients highlight underlying US population differences rather than differences in MS disease severity.
Authors: Perri Zeitz Ruckart; Adrienne S Ettinger; Mona Hanna-Attisha; Nicole Jones; Stephanie I Davis; Patrick N Breysse Journal: J Public Health Manag Pract Date: 2019 Jan/Feb
Authors: J C Arango-Lasprilla; D Rivera; S Trapp; C Jiménez-Pérez; C L Hernández Carrillo; S Pohlenz Amador; E Vergara-Moragues; Y Rodríguez-Agudelo; W Rodriguez-Irizarry; C García de la Cadena; A Galvao-Carmona; J Galarza-Del-Angel; X Llerena Espezúa; N Torales Cabrera; P Flor-Caravia; A Aguayo Arelis; M Saracostti Schwartzman; R Barranco Casimiro; N Albaladejo-Blázquez Journal: NeuroRehabilitation Date: 2017 Impact factor: 2.138
Authors: Annette Langer-Gould; Robyn Lucas; Anny H Xiang; Lie H Chen; Jun Wu; Edlin Gonzalez; Samantha Haraszti; Jessica B Smith; Hong Quach; Lisa F Barcellos Journal: Nutrients Date: 2018-02-27 Impact factor: 5.717
Authors: Annette F Okai; Annette M Howard; Mitzi J Williams; Justine D Brink; Chiayi Chen; Tamela L Stuchiner; Elizabeth Baraban; Grace Jeong; Stanley L Cohan Journal: Neurology Date: 2022-04-25 Impact factor: 11.800
Authors: Daniela A Pimentel Maldonado; Justin R Eusebio; Lilyana Amezcua; Eleni S Vasileiou; Ellen M Mowry; Christopher C Hemond; Raffaella Umeton Pizzolato; Idanis Berrios Morales; Irina Radu; Carolina Ionete; Kathryn C Fitzgerald Journal: Mult Scler Relat Disord Date: 2021-12-05 Impact factor: 4.808